Cargando…

Open science approaches to COVID-19

In only a matter of months, the coronavirus disease of 2019 (COVID-19) has spread around the world. The global impact of the disease has caused significant and repeated calls for quick action towards new medicines and vaccines. In response, researchers have adopted open science methods to begin to c...

Descripción completa

Detalles Bibliográficos
Autores principales: Tse, Edwin G., Klug, Dana M., Todd, Matthew H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7590891/
https://www.ncbi.nlm.nih.gov/pubmed/33145011
http://dx.doi.org/10.12688/f1000research.26084.1
_version_ 1783600885758164992
author Tse, Edwin G.
Klug, Dana M.
Todd, Matthew H.
author_facet Tse, Edwin G.
Klug, Dana M.
Todd, Matthew H.
author_sort Tse, Edwin G.
collection PubMed
description In only a matter of months, the coronavirus disease of 2019 (COVID-19) has spread around the world. The global impact of the disease has caused significant and repeated calls for quick action towards new medicines and vaccines. In response, researchers have adopted open science methods to begin to combat this disease via global collaborative efforts. We summarise here some of those initiatives, and have created an updateable list to which others may be added. Though open science has previously been shown as an accelerator of biomedical research, the COVID-19 crisis has made openness seem the logical choice. Will openness persist in the discovery of new medicines, after the crisis has receded?
format Online
Article
Text
id pubmed-7590891
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher F1000 Research Limited
record_format MEDLINE/PubMed
spelling pubmed-75908912020-11-02 Open science approaches to COVID-19 Tse, Edwin G. Klug, Dana M. Todd, Matthew H. F1000Res Review In only a matter of months, the coronavirus disease of 2019 (COVID-19) has spread around the world. The global impact of the disease has caused significant and repeated calls for quick action towards new medicines and vaccines. In response, researchers have adopted open science methods to begin to combat this disease via global collaborative efforts. We summarise here some of those initiatives, and have created an updateable list to which others may be added. Though open science has previously been shown as an accelerator of biomedical research, the COVID-19 crisis has made openness seem the logical choice. Will openness persist in the discovery of new medicines, after the crisis has receded? F1000 Research Limited 2020-08-25 /pmc/articles/PMC7590891/ /pubmed/33145011 http://dx.doi.org/10.12688/f1000research.26084.1 Text en Copyright: © 2020 Tse EG et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Tse, Edwin G.
Klug, Dana M.
Todd, Matthew H.
Open science approaches to COVID-19
title Open science approaches to COVID-19
title_full Open science approaches to COVID-19
title_fullStr Open science approaches to COVID-19
title_full_unstemmed Open science approaches to COVID-19
title_short Open science approaches to COVID-19
title_sort open science approaches to covid-19
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7590891/
https://www.ncbi.nlm.nih.gov/pubmed/33145011
http://dx.doi.org/10.12688/f1000research.26084.1
work_keys_str_mv AT tseedwing openscienceapproachestocovid19
AT klugdanam openscienceapproachestocovid19
AT toddmatthewh openscienceapproachestocovid19